Patents by Inventor Peter Slavny

Peter Slavny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENTARITY-DETERMINING REGIONS FOR BINDING CD3, AND BISPECIFIC ANTIGEN-BINDING MOLECULE CONTAINING SAID CDRS
    Publication number: 20230212288
    Abstract: The invention relates to the field of immunology and biotechnology, and also to the creation of novel effective high-molecular compounds having therapeutic properties. Variants of amino acid sequences of complementarity-determining regions (CDR) of antigen-binding fragments of a protein molecule specific to human cell CD3 receptors are proposed. The proposed CDR can be used for engineering various antigen-binding molecules, one of the essential function of which is a specific interaction with CD3-bearing cells. Bispecific molecules that specifically bind to human cell CD3 and CD19 receptors were engineered by means of the inclusion of said CDR in the composition of an antibody-like molecule intrinsically binding to the CD19 receptor.
    Type: Application
    Filed: August 20, 2020
    Publication date: July 6, 2023
    Inventors: Aleksandr Aleksandrovich PISKUNOV, Svetlana Georgievna ABBASOVA, Anton Nikolaevich MOROZOV, Aleksandr Mikhailovich SHUSTER, Peter SLAVNY, Daniel GRIFFITHS, Izabela KACZYNSKA, John MCCAFFERTY, Michael DYSON
  • Anti-CXCL12 antibody molecules and their uses
    Patent number: 10647766
    Abstract: Anti-CXCL12 antibody molecules and their uses are disclosed, and in particular anti-CXCL12 antibody molecules that are capable of inhibiting a biological activity of CXCL12 in vitro and in vivo and their use for treating CXCL12-mediated disease.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: May 12, 2020
    Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Frances Rosemary Balkwill, John McCafferty, Gerard John Graham, Aneesh Karatt Vellatt, Peter Slavny
  • Anti-CXCL12 Antibody Molecules and Their Uses
    Publication number: 20170362314
    Abstract: Anti-CXCL12 antibody molecules and their uses are disclosed, and in particular anti-CXCL12 antibody molecules that are capable of inhibiting a biological activity of CXCL12 in vitro and in vivo and their use for treating CXCL12-mediated disease.
    Type: Application
    Filed: December 11, 2015
    Publication date: December 21, 2017
    Inventors: Frances Rosemary Balkwill, John McCafferty, Gerard John Graham, Aneesh Karatt Vellatt, Peter Slavny